Health Care Sector News

Latest News

  • Airbus CEO lashes out at Austria over fraud probe Reuters - UK Focus - 6 minutes ago

    PARIS/VIENNA, April 27 (Reuters) - A heated row broke out between Austria and Europe's largest aerospace company on Thursday as Airbus Chief Executive Tom Enders accused Vienna of playing politics with a fraud investigation and the government told him to calm down. The exchange came 24 hours after Reuters first reported …

  • This non-cyclical growth stock's large and growing dividends have me very interested.

  • Last chance to buy GlaxoSmithKline plc for under £16? Fool.co.uk - 2 hours 49 minutes ago

    Is now the perfect time to buy a stake in GlaxoSmithKline plc (LON:GSK)?

  • Drugs firms threaten UK exit unless NHS gets £20bn extra per year

    The pharmaceutical industry has issued a stinging election threat, suggesting firms could withdraw from the UK and delay drug launches unless the NHS gets a huge funding boost. The Association of the British Pharmaceutical Industry's (ABPI's) self-styled " manifesto " demands an increase in health spending from 9.9% to …

  • Roland Head highlights two stocks with the potential for long-term income growth.

  • AstraZeneca (NYSE: AZN - news) , struggling with loss of patents on blockbusters like cholesterol pill Crestor, reported another quarter of falling drug sales on Thursday as it awaits pivotal clinical trial data that may revive its fortunes. Chief Executive Pascal Soriot believes 2017 will mark the trough for the British …

  • British biotech firm Synairgen lost nearly half its value on Thursday as partner AstraZeneca pulled the plug on an experimental drug designed to help patients fight common cold viruses. AstraZeneca announced ...

  • AstraZeneca (NYSE: AZN - news) 's chief executive said on Thursday his company remained "very committed" to investment in Britain, despite challenges in the UK market. Drugmakers are concerned at low healthcare spending and limited use of new drugs in the National Health Service, which results in French and German patients …

  • A poll out this morning has confirmed the suspicion that French presidential favourite Emmanuel Macron is struggling to get his campaign off the ground for the second round on May 7. The Elabe survey found ...

  • AstraZeneca (NYSE: AZN - news) , struggling with loss of patents on blockbusters like cholesterol pill Crestor, reported another quarter of falling drug sales on Thursday as it awaits pivotal clinical trial data that may revive its fortunes. Despite income from disposals and external deals, first-quarter revenue fell …

  • PARIS--(BUSINESSWIRE)-- Primary Care division to become Consumer Healthcare Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical group, today announced sales for ...

  • Earnings support Britain's FTSE, StanChart leads banks higher Reuters - UK Focus - Wed, Apr 26, 2017 17:20 BST

    British shares rose on Wednesday as gains for Standard Chartered and other companies reporting well-received results helped offset a pullback in healthcare stocks. The blue-chip FTSE 100 index closed up ...

  • 2 FTSE 250 bargains I’d buy before it’s too late Fool.co.uk - Wed, Apr 26, 2017 16:11 BST

    These FTSE 250 (INDEXFTSE:MCX) stocks look set for strong growth.

  • New GlaxoSmithKline CEO wants fewer, bigger new drug launches Reuters - UK Focus - Wed, Apr 26, 2017 15:55 BST

    GlaxoSmithKline (Other OTC: GLAXF - news) 's new chief executive aims to improve returns in drug development, and wants fewer but bigger new medicine launches. In her first comments since taking over on April 1, Emma Walmsley, 47, said on Wednesday that her priority was the pharmaceuticals unit, where she wants commercial …

  • Bulgaria opts for Swedish Gripen combat jets Reuters - UK Focus - Wed, Apr 26, 2017 12:14 BST

    Bulgaria has decided to start talks with Sweden to acquire eight new Gripen combat jets made by SAAB (LSE: 0GWL.L - news) , interim deputy prime minister Stefan Yanev said on Wednesday, as the Balkan (LSE: 0IS4.L - news) country seeks to replace its ageing Soviet-designed MiG (Shenzhen: 300242.SZ - news) -29s. A special …

  • Weak sterling boosts GlaxSmithKline as new CEO takes over Reuters - UK Focus - Wed, Apr 26, 2017 12:10 BST

    GlaxoSmithKline's new chief executive reported slightly better than expected first-quarter results on Wednesday, keeping the drugmaker on track to hit financial targets in 2017 as it braces for generic ...

  • Bulgaria opts for Swedish Gripen combat jets Reuters - UK Focus - Wed, Apr 26, 2017 11:43 BST

    Bulgaria has decided to start talks with Sweden to acquire eight new Gripen combat jets made by SAAB, interim deputy prime minister Stefan Yanev said on Wednesday. The Balkan country has picked the Swedish ...

  • AstraZeneca third-line lung cancer trial delayed by few months Reuters - UK Focus - Wed, Apr 26, 2017 11:11 BST

    A clinical study testing AstraZeneca (NYSE: AZN - news) 's experimental immunotherapy drugs in lung cancer patients who have already received at least two previous treatments will take longer than initially expected to produce results. AstraZeneca had previously said it expected results in the first half of 2017. The …

  • Britain's FTSE little changed as focus turns to earnings Reuters - UK Focus - Wed, Apr 26, 2017 11:05 BST

    British shares were flat on Wednesday, with gains for Standard Chartered and other companies that reported well-received earnings updates helping to offset a pullback in healthcare stocks. The blue-chip ...

  • ADR: IPSEY) announces the publication of the resolutions proposed by its Board of Directors to its next Shareholders’ Meeting to be held on June 7, 2017 at 3:00 pm at the Maison des Arts et Métiers in Paris in the Bulletin des annonces légales obligatoires. Dr. Margaret Liu is a worldwide distinguished scientist who …

  • British shares edged higher on Tuesday as a strong Europe-wide market rally after the first round of the French election dissipated and investors focused on corporate results which indicated tougher times ...

  • Novartis sets sights on return to growth in 2018 Reuters - UK Focus - Tue, Apr 25, 2017 16:39 BST

    Novartis (IOB: 0QLR.IL - news) reported better-than-expected first-quarter profits on Tuesday with Chief (Taiwan OTC: 3345.TWO - news) Executive Joe Jimenez saying he remained confident the Swiss drugmaker would return to growth in 2018 as spending to promote new drugs pays off. First (Other OTC: FSTC - news) -quarter …

  • Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm?

  • 2 FTSE 100 growth giants that could help you retire early Fool.co.uk - Tue, Apr 25, 2017 16:00 BST

    These FTSE 100 (INDEXFTSE:UKX) growth stocks could be big winners, says G A Chester.

  • AstraZeneca moving costs rise as new HQ nears completion Reuters - UK Focus - Tue, Apr 25, 2017 14:00 BST

    AstraZeneca (NYSE: AZN - news) 's move to the English university city of Cambridge will cost more and take longer than initially expected, following increased expenditure on new technology and equipment. Investment in Cambridge, where AstraZeneca is building a strategic R&D centre and global corporate headquarters, is …

  • British shares edged up on Tuesday as a strong Europe-wide market rally after the first round of the French election dissipated, with investors' focus back on corporate results which indicated tougher ...

  • 2 FTSE 100 dividend stocks for beginners Fool.co.uk - Tue, Apr 25, 2017 09:41 BST

    If you don't know where to start, these dividend stocks can help you build your portfolio from scratch.

  • These two different stocks in the same sector strike a happy balance, says Harvey Jones.

  • Kids Company bosses face directorship ban over 2015 collapse

    The founder and former trustees of Kids Company face being banned from serving as company directors after the charity collapsed in 2015 amid allegations of serious financial mismanagement. Sky News has learnt that the Government's Insolvency Service has written to lawyers acting for Kids Company's former board members …

  • Kids Company bosses face directorship ban over 2015 collapse

    The founder and former trustees of Kids Company face being banned from serving as company directors after the charity collapsed in 2015 amid allegations of serious financial mismanagement. Sky News has learnt that the Government's Insolvency Service has written to lawyers acting for Kids Company's former board members …

  • Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018 Reuters - UK Focus - Mon, Apr 24, 2017 09:00 BST

    Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said on Monday. The injectable vaccine, called RTS,S or Mosquirix, was developed by British drugmaker GlaxoSmithKline (Other …

  • Frankfurt Stock Exchange Prime Standard: MGN) announced the key results of the exploratory phase II IMPULSE study. The randomized study evaluated the efficacy and safety of lefitolimod in patients with extensive-disease small-cell lung cancer (SCLC). The results of this SCLC study provide significant guidance for …

  • Anglo American reports 9 percent rise in output Reuters - UK Focus - Mon, Apr 24, 2017 08:52 BST

    Anglo American (LSE: AAL.L - news) reported a 9 percent rise in overall production for the first quarter of 2017 compared with 2016, but copper output fell 3 percent due to poorer grades and a temporary suspension at the El Soldado mine in Chile (Stuttgart: 704599.SG - news) . The company had no fatalities in the first …

  • Anglo American reports 9 percent output rise, but copper down Reuters - UK Focus - Mon, Apr 24, 2017 07:24 BST

    Anglo American on Monday reported a 9 percent rise in overall production for the first quarter of 2017 compared with 2016, but copper output fell 3 percent due to poorer grades and a temporary suspension ...

  • EU drugmakers urge June decision on new location for watchdog Reuters - UK Focus - Sun, Apr 23, 2017 23:01 BST

    Europe's drugmakers pushed for a decision as early as June on the new location for the headquarters of the bloc's medicines watchdog, which will relocate from London after Britain's decision to leave the EU. The new location will be decided by the EU's heads of state, whose next meeting as the European Council is scheduled …

Next >>